Active Ingredient: TAFLUPROST
Proprietary Name: TAFLUPROST
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: 0.0015%
Reference Listed Drug: No
Reference Standard: No
TE Code: AT
Application Number: A218002
Product Number: 001
Approval Date: Apr 5, 2024
Applicant Holder Full Name: INGENUS PHARMACEUTICALS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information